Preoperative Arterial Embolization for Heterotopic Ossification of the Hip

J Vasc Interv Radiol. 2023 Apr;34(4):608-612. doi: 10.1016/j.jvir.2022.11.030. Epub 2022 Dec 5.

Abstract

Purpose: To investigate the efficacy and safety of preoperative arterial embolization for neurogenic heterotopic ossification (NHO) of the hip.

Materials and methods: This single-center retrospective study reviewed outcomes in 16 consecutive patients who had surgical resection of NHO of the hip: 8 of whom underwent preoperative arterial embolization and 8 of whom did not. Both patient cohorts had similar baseline characteristics. A mean of 2.62 ± 1.9 arteries per patient, including the gluteal, lateral circumflex femoral, and deep circumflex iliac branches, were embolized using an n-butyl cyanoacrylate (NBCA)-ethiodized oil mixture. Data from both cohorts regarding intraoperative blood loss, volume of blood transfused, complications, and duration of hospitalization were compared.

Results: A mean of 2.6 ± 1.9 arteries were embolized with NBCA-ethiodized oil, mainly the gluteal arteries, lateral circumflex femoral artery, and deep circumflex iliac artery. In the embolization group, mean intraoperative blood loss was 875 mL ± 320, mean number of units of blood used was 0.5 ± 0.7, and mean number of days of hospitalization was 6.4 days ± 1.6. In the control group, mean intraoperative blood loss was 1,350 mL ± 120, mean number of units of blood used was 2 ± 1.1, and average number of days of hospitalization was 11.5 days ± 1.4. The embolization group had a mean reduction in blood loss of 40.7% (P = 0.035), reduction in units of blood administered of 75% (P = 0.021), and reduction in days of hospitalization of 44.7% (P = 0.014). No procedural complications were recorded.

Conclusions: Preoperative arterial embolization is effective and safe in reducing intraoperative blood loss, number of hospitalization days, and need for blood transfusions in surgical resection of NHO of the hip.

MeSH terms

  • Blood Loss, Surgical / prevention & control
  • Embolization, Therapeutic* / adverse effects
  • Enbucrilate* / adverse effects
  • Ethiodized Oil
  • Humans
  • Ossification, Heterotopic* / diagnostic imaging
  • Ossification, Heterotopic* / etiology
  • Ossification, Heterotopic* / therapy
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Ethiodized Oil
  • Enbucrilate